Hesperidin and Diosmin for Treatment of COVID-19
NCT04452799
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Coronavirus Infection
Interventions
DRUG:
Hesperidin and Diosmin mixture
Sponsor
Tanta University